Private Equity

A new venture plans to transform Los Angeles's legacy oil fields into clean power plants for the AI industry, bypassing an already strained energy grid.

Eton Pharmaceuticals wins landmark FDA approval for DESMODA, a breakthrough liquid drug set to transform care for a rare condition by enabling precise, safe dosing.

Silfab Solar appoints financial veteran Phung Ngo-Burns as CFO, a strategic move to navigate its major U.S. expansion amid a booming domestic solar market.

BearCom installs its executive chairman as interim CEO, a move signaling a focused push to dominate the converging security and communications markets.

A $1.12M Baltimore deal for an Ethiopian investor reveals how private capital is bypassing traditional banks to fuel global investment in American property.

Following a record year, Fingerpaint Group elevates veteran insiders to top roles, proving its culture-first succession strategy is a blueprint for success.

A new lineup of seasonings taps into global, comfort, and sweet-heat trends to help meat processors navigate a volatile and competitive market.

As CFO Jim Kelly retires, Orbia promotes Cristian Capellino, the architect of its finance modernization, ensuring strategic continuity and focus on growth.

The deal merges local surveying expertise with national geospatial power, reshaping the infrastructure services landscape in fast-growing Central Texas.

Black Bear Sports Group promises multi-million dollar upgrades for two local ice arenas, but its controversial business model raises concerns for families.

Amid a surge in MedTech M&A, Piper Sandler appoints 25-year veteran Aamer Naseer to steer its life sciences outsourcing and B2B technology groups.

Facing financial headwinds, Mint Inc. pivots into the high-stakes world of AI, unveiling the FLOKI Minibot M1, a personalized companion for Asia.

Struggling biotech Jupiter Neurosciences presents its Parkinson's drug to elite investors at Mar-a-Lago, betting its hybrid business model can win funding.

Facing DEI headwinds, the Diversity Action Alliance unveils a new strategy and its most diverse board yet, reframing inclusion as a business imperative.

Backed by 1.2M citizens and 8 former world leaders, the 'My Voice, My Choice' initiative puts European democracy and reproductive rights at a crossroads.

Advantage Solutions overhauls its board, adding heavyweights in capital markets and commercial strategy to navigate a pivotal transformation and retail industry shifts.

With funding from a mining giant, Finlay Minerals' latest results identify three major drill-ready copper-gold targets in BC's Toodoggone district.

With legendary geologist Doug Kirwin and Latin America expert Carlos Velásquez on board, Terra Rossa is set to unlock its high-grade Vetas gold project.

As Evolus presents at a key healthcare conference, investors watch to see if its new filler line and digital strategy can deliver on bold promises.

Investors sue Corcept Therapeutics, claiming the company hid FDA warnings about its key drug, relacorilant, before a 50% stock price collapse.